OLZEBY Trademark

Trademark Overview


On Thursday, May 9, 2024, a trademark application was filed for OLZEBY with the United States Patent and Trademark Office. The USPTO has given the OLZEBY trademark a serial number of 98541708. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 29, 2024. This trademark is owned by Teva Pharmaceuticals International GmbH. The OLZEBY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations, namely, anti-psychotics.
olzeby

General Information


Serial Number98541708
Word MarkOLZEBY
Filing DateThursday, May 9, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations, namely, anti-psychotics.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals International GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressJona 8645
CH

Party NameTeva Pharmaceuticals International GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJona 8645
CH

Trademark Events


Event DateEvent Description
Thursday, May 9, 2024NEW APPLICATION ENTERED
Thursday, May 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2024ASSIGNED TO EXAMINER
Saturday, September 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 29, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED